Consumers were more willing to buy unlabeled produce after being shown food tagged as “genetically modified” in a new Cornell study that comes two months before a new federal food-labeling law goes into effect.
A high-salt diet may impair cognitive function by causing a deficiency of nitric oxide, which is vital for maintaining vascular health in the brain, according to a new study from Weill Cornell Medicine.
Powerful lab and computational techniques developed by scientists at Weill Cornell Medicine and two other centers will enable scientists to map tumors’ ability to develop resistance to drugs.
“Health Inequities,” a new episode of the “What Makes Us Human” podcast series, explores how “sociological” storytelling can change health outcomes with Jeff Niederdeppe, associate professor of communication.
A universal influenza vaccine developed with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases.
With a grant of $2,355,000 over five years, Marcos Simoes-Costa, assistant professor of molecular biology and genetics, will investigate how the spatial complexity of an organism is generated in early development.
New cellular and molecular processes underlying communication between gut microbes and brain cells have been described for the first time by scientists at Weill Cornell Medicine and Cornell’s Ithaca campus.
Dr. Rainu Kaushal, chair of the Department of Healthcare Policy and Research at Weill Cornell Medicine, has been elected to the National Academy of Medicine
With a pinch of pomp and circumstance, Cornell’s McGovern Center life sciences business incubator recently graduated two companies – Bactana Corp. and Conamix.
